Description:
CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company is headquartered in Vienna, Virginia.
Address:
8229 BOONE BOULEVARD, VIENNA, VA, UNITED STATES, 22182
Fiscal year end:
September
Market capitalization:
$24.1 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-100%
How much will you get:
$3
Prices dates:
30-06-2016: $345.00 and 30-06-2026: $1.04